1. Home
  2. SYRE vs LOT Comparison

SYRE vs LOT Comparison

Compare SYRE & LOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • LOT
  • Stock Information
  • Founded
  • SYRE 2013
  • LOT 1948
  • Country
  • SYRE United States
  • LOT China
  • Employees
  • SYRE N/A
  • LOT N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • LOT
  • Sector
  • SYRE Health Care
  • LOT
  • Exchange
  • SYRE Nasdaq
  • LOT NYSE
  • Market Cap
  • SYRE 1.1B
  • LOT 956.3M
  • IPO Year
  • SYRE 2016
  • LOT N/A
  • Fundamental
  • Price
  • SYRE $16.26
  • LOT $1.90
  • Analyst Decision
  • SYRE Buy
  • LOT
  • Analyst Count
  • SYRE 5
  • LOT 0
  • Target Price
  • SYRE $55.00
  • LOT N/A
  • AVG Volume (30 Days)
  • SYRE 545.5K
  • LOT 84.0K
  • Earning Date
  • SYRE 08-06-2025
  • LOT 08-27-2025
  • Dividend Yield
  • SYRE N/A
  • LOT N/A
  • EPS Growth
  • SYRE N/A
  • LOT N/A
  • EPS
  • SYRE N/A
  • LOT N/A
  • Revenue
  • SYRE N/A
  • LOT $844,090,000.00
  • Revenue This Year
  • SYRE N/A
  • LOT $28.31
  • Revenue Next Year
  • SYRE N/A
  • LOT $106.32
  • P/E Ratio
  • SYRE N/A
  • LOT N/A
  • Revenue Growth
  • SYRE N/A
  • LOT 1.33
  • 52 Week Low
  • SYRE $10.91
  • LOT $1.06
  • 52 Week High
  • SYRE $40.26
  • LOT $6.49
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 48.34
  • LOT 35.03
  • Support Level
  • SYRE $16.43
  • LOT $2.27
  • Resistance Level
  • SYRE $17.70
  • LOT $2.14
  • Average True Range (ATR)
  • SYRE 0.99
  • LOT 0.15
  • MACD
  • SYRE -0.02
  • LOT -0.05
  • Stochastic Oscillator
  • SYRE 37.17
  • LOT 2.44

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About LOT LOTUS TECHNOLOGY INC

Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.

Share on Social Networks: